4733:TSEOBIC Business Consultants Co., Ltd. Analysis
Data as of 2026-06-12 - not real-time
¥5,866.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
The 20‑day SMA has slipped beneath both the 50‑day and the 200‑day SMA, while the RSI hovers around the mid‑range and the MACD line remains negative, all pointing to a bearish technical outlook with a clear support level below the current price and a resistance ceiling above it. High 30‑day volatility and a low beta further underscore the market’s tentative stance, though volume remains stable.
On the fundamentals side, the company posts a solid revenue growth rate, exceptionally high gross and operating margins, and a profit margin exceeding one‑third. With zero debt, a massive cash reserve, and a dividend yield of just over two percent supported by a payout ratio under fifty percent, the financial health is robust. However, the current price exceeds the DCF‑derived fair value, suggesting a modest overvaluation despite a P/E ratio that is lower than the industry average. The blend of strong earnings, cash‑rich balance sheet, and dividend sustainability aligns with the internal “strong‑buy” recommendation.
On the fundamentals side, the company posts a solid revenue growth rate, exceptionally high gross and operating margins, and a profit margin exceeding one‑third. With zero debt, a massive cash reserve, and a dividend yield of just over two percent supported by a payout ratio under fifty percent, the financial health is robust. However, the current price exceeds the DCF‑derived fair value, suggesting a modest overvaluation despite a P/E ratio that is lower than the industry average. The blend of strong earnings, cash‑rich balance sheet, and dividend sustainability aligns with the internal “strong‑buy” recommendation.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 7/10
Key Factors
- bearish technical indicators (SMA, RSI, MACD)
- price exceeds DCF valuation
- stable volume with high volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- strong revenue growth and high profit margins
- zero debt and abundant cash
- internal strong‑buy recommendation
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- sustainable dividend and low payout ratio
- robust balance sheet and cash flow
- steady growth trajectory despite current overvaluation
Key Metrics & Analysis
Financial Health
Revenue Growth10.70%
Profit Margin35.28%
P/E Ratio24.3
ROE11.04%
ROA6.86%
P/B Ratio2.6
Op. Cash Flow¥17.4B
Free Cash Flow¥12.6B
Industry P/E36.5
Technical Analysis
TrendBearish
RSI40.0
Support¥5,785.00
Resistance¥6,509.00
MA 20¥6,091.00
MA 50¥6,231.58
MA 200¥7,542.15
MACDBearish
VolumeStable
Fear & Greed Index86.71
Valuation
Fair Value¥4,967.19
Target Price¥8,650.00
Upside/Downside47.46%
GradeOvervalued
TypeBlend
Dividend Yield2.19%
Risk Assessment
Beta0.23
Volatility27.34%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.